Prescription of Extended-Duration Thromboprophylaxis After High-Risk, Abdominopelvic Cancer Surgery

Gynecologic Oncology - United States
doi 10.1016/j.ygyno.2016.03.023
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Extended Versus Inpatient Thromboprophylaxis With Heparins Following Major Open Abdominopelvic Surgery for Malignancy: A Systematic Review of Efficacy and Safety

Perioperative Medicine
2020English

Extended Pharmacologic Thromboprophylaxis in Oncologic Liver Surgery Is Safe and Effective

Journal of Thrombosis and Haemostasis
MedicineHematology
2017English

Duration of Pharmacological Thromboprophylaxis After Outpatient Endovenous Laser Ablation: A Propensity Score-Matched Analysis

Swiss Medical Weekly
Medicine
2019English

Admission Lactate and Outcome After High-Risk Surgery

Critical Care
Critical CareIntensive Care Medicine
2012English

Prognosis of the Parotid Cancer and Reconstructive Surgery After Extended Total Parotidectomy

Japanese jornal of Head and Neck Cancer
1989English

Postoperative Pharmacologic Thromboprophylaxis With Enoxaparin and Thrombotic Complications After Liver Surgery

HPB
HepatologyGastroenterology
2018English

Emerging Options for Thromboprophylaxis After Orthopedic Surgery: A Review of Clinical Data

Pharmacotherapy
Pharmacology
2004English

Venous Thromboprophylaxis in Spine Surgery

Global Spine Journal
OrthopedicsSurgeryNeurologySports Medicine
2019English

Time-To-Readmission and Mortality After High-Risk Surgery

Annals of Surgery
Surgery
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy